• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX, INC. AFX; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX, INC. AFX; BIFURCATED STENT GRAFT Back to Search Results
Model Number BA28-90/I20-30
Device Problems Deformation Due to Compressive Stress (2889); Insufficient Information (3190)
Patient Problem Failure of Implant (1924)
Event Date 11/06/2019
Event Type  Injury  
Manufacturer Narrative
The devices involved in this event will not be returned for evaluation and remain implanted in the patient.If additional information is obtained at a later time that is pertinent to this event, a follow-up report will then be submitted.Insufficient device information received to determine device iteration.Device iteration will be provided when further information.
 
Event Description
The patient was initially treated for an abdominal aortic aneurysm (aaa) with the afx abdominal aortic aneurysm stent.Approximately three and a half (3.5) years post initial procedure, the patient presented with an unknown device failure.The physician plans to re-intervene and will continue to monitor the patient.As of date, there have been no additional patient sequelae reported.There is limited information available regarding the initial reported event.
 
Manufacturer Narrative
The manufacturing lot evaluation confirmed all devices met specifications prior to release.The device was not returned as the device remains implanted therefore no evaluation was completed.At the completion of the clinical assessment, the reported unknown device failure was identified as a type 3a endoleak with buckling of the bifurcated stent graft.Procedure related harms, device, user, procedure or anatomy relatedness of this event could not be determined with the medical records / images available for review.The following contributing factors were identified; the proximal extension was not in optimal position.It is not possible to determine migration vs suboptimal implant placement without comparative imaging.The extreme 82° aortic angulation likely contributed to the type 3a endoleak.It is not possible to identify whether this was an off-label condition or was due to aortic remodeling without comparative imaging.The buckling of the main body was most likely due to the extreme angulation of the aorta.No additional investigation of this reported event is planned however if additional information pertinent to the incident is obtained, a follow-up report will be submitted.Endologix will continue to monitor this complaint and similar complaints in the event further investigation is needed.Device iteration is afx with duraply.Corrections: h6: device code: remove code 3190 h6: result code: remove code 3233 h6: conclusion code: remove code 11.
 
Event Description
The patient was initially treated for an abdominal aortic aneurysm (aaa) with the afx abdominal aortic aneurysm stent.Approximately three and a half (3.5) years post initial procedure, the patient presented with an unknown device failure.The physician plans to re-intervene and will continue to monitor the patient.As of date, there have been no additional patient sequelae reported.There is limited information available regarding the initial reported event.Additional information received: the patient was initially implanted with a bifurcated stent graft and a suprarenal stent graft extension to treat an abdominal aortic aneurysm (aaa).The reported unknown device failure was identified to be a type 3a endoleak and buckling of the bifurcated stent graft.No further information was provided regarding the re- intervention.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX, INC.
2 musick
irvine CA 92618
MDR Report Key9527733
MDR Text Key175056208
Report Number2031527-2019-00628
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Recall
Type of Report Initial,Followup
Report Date 11/27/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/07/2019
Device Model NumberBA28-90/I20-30
Device Lot Number1434493-019
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/27/2019
Initial Date FDA Received12/27/2019
Supplement Dates Manufacturer Received11/27/2019
Supplement Dates FDA Received05/13/2020
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberZ-0006-2019
Patient Sequence Number1
Treatment
VELA SUPRARENAL, LOT 1346818008
Patient Outcome(s) Other;
Patient Age75 YR
-
-